Foyez Mahmud

427 total citations
17 papers, 332 citations indexed

About

Foyez Mahmud is a scholar working on Molecular Biology, Oncology and Biomaterials. According to data from OpenAlex, Foyez Mahmud has authored 17 papers receiving a total of 332 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Biomaterials. Recurrent topics in Foyez Mahmud's work include Nanoparticle-Based Drug Delivery (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Foyez Mahmud is often cited by papers focused on Nanoparticle-Based Drug Delivery (4 papers), Angiogenesis and VEGF in Cancer (4 papers) and Drug Transport and Resistance Mechanisms (3 papers). Foyez Mahmud collaborates with scholars based in South Korea, United States and Puerto Rico. Foyez Mahmud's co-authors include Youngro Byun, Taslim A. Al‐Hilal, Farzana Alam, Sang Yoon Kim, Seung Woo Chung, Jooho Park, Jeong Uk Choi, Duane D. Miller, Seho Kweon and Han Sung Kim and has published in prestigious journals such as Biomaterials, The FASEB Journal and Journal of Controlled Release.

In The Last Decade

Foyez Mahmud

17 papers receiving 325 citations

Peers

Foyez Mahmud

ONCOL

BIOMA

Pei‐Yin Ho Taiwan

Subhash C. Chauhan United States

María José Guillén Spain

Felix Boakye‐Agyeman United States

Peri Nagappan United States

Chengan Du United States

Haneen A. Basheer Jordan

Kuan-Boone Tan Singapore

Po‐Han Chao Canada

Hongxia Lin South Korea

Pei‐Yin Ho Taiwan

Foyez Mahmud

203 ×1.4

78 ×0.9

ONCOL

47 ×0.9

44 ×0.9

BIOMA

13 ×0.4

Citations per year, relative to Foyez Mahmud Foyez Mahmud (= 1×) peers Pei‐Yin Ho

Countries citing papers authored by Foyez Mahmud

Since Specialization

Citations

This map shows the geographic impact of Foyez Mahmud's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Foyez Mahmud with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Foyez Mahmud more than expected).

Fields of papers citing papers by Foyez Mahmud

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Foyez Mahmud. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Foyez Mahmud. The network helps show where Foyez Mahmud may publish in the future.

Co-authorship network of co-authors of Foyez Mahmud

This figure shows the co-authorship network connecting the top 25 collaborators of Foyez Mahmud. A scholar is included among the top collaborators of Foyez Mahmud based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Foyez Mahmud. Foyez Mahmud is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Roy, Ruchi, et al.. (2023). Reduced Bioactive Microbial Products (Pathogen-Associated Molecular Patterns) Contribute to Dysregulated Immune Responses and Impaired Healing in Infected Wounds in Mice with Diabetes. Journal of Investigative Dermatology. 144(2). 387–397.e11. 10 indexed citations

Mahmud, Foyez, Ruchi Roy, Mohamed F. Mohamed, et al.. (2021). Therapeutic evaluation of immunomodulators in reducing surgical wound infection. The FASEB Journal. 36(1). e22090–e22090. 10 indexed citations

Banerjee, Souvik, Shalini Yadav, Sourav Banerjee, et al.. (2021). Drug Repurposing to Identify Nilotinib as a Potential SARS-CoV-2 Main Protease Inhibitor: Insights from a Computational and In Vitro Study. Journal of Chemical Information and Modeling. 61(11). 5469–5483. 30 indexed citations

Banerjee, Souvik, Foyez Mahmud, Shanshan Deng, et al.. (2021). X-ray Crystallography-Guided Design, Antitumor Efficacy, and QSAR Analysis of Metabolically Stable Cyclopenta-Pyrimidinyl Dihydroquinoxalinone as a Potent Tubulin Polymerization Inhibitor. Journal of Medicinal Chemistry. 64(17). 13072–13095. 21 indexed citations

Mahmud, Foyez, Shanshan Deng, Hao Chen, Duane D. Miller, & Wěi Li. (2020). Orally available tubulin inhibitor VERU-111 enhances antitumor efficacy in paclitaxel-resistant lung cancer. Cancer Letters. 495. 76–88. 25 indexed citations

Chung, Seung Woo, Seho Kweon, Jeong Uk Choi, et al.. (2018). Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment. Biomaterials. 182. 35–43. 23 indexed citations

Mahmud, Foyez, Farzana Alam, Jeong Uk Choi, et al.. (2018). Oral pemetrexed facilitates low-dose metronomic therapy and enhances antitumor efficacy in lung cancer. Journal of Controlled Release. 284. 160–170. 10 indexed citations

Mahmud, Foyez, Seung Woo Chung, Farzana Alam, et al.. (2017). Metronomic chemotherapy using orally active carboplatin/deoxycholate complex to maintain drug concentration within a tolerable range for effective cancer management. Journal of Controlled Release. 249. 42–52. 10 indexed citations

Choi, Jeong Uk, Seung Woo Chung, Taslim A. Al‐Hilal, et al.. (2017). A heparin conjugate, LHbisD4, inhibits lymphangiogenesis and attenuates lymph node metastasis by blocking VEGF-C signaling pathway. Biomaterials. 139. 56–66. 24 indexed citations

10.

Chung, Seung Woo, Seho Kweon, Beom Suk Lee, et al.. (2017). Radiotherapy‐assisted tumor selective metronomic oral chemotherapy. International Journal of Cancer. 141(9). 1912–1920. 8 indexed citations

11.

Alam, Farzana, Taslim A. Al‐Hilal, Jooho Park, et al.. (2016). Multi-stage inhibition in breast cancer metastasis by orally active triple conjugate, LHTD4 (low molecular weight heparin-taurocholate-tetrameric deoxycholate). Biomaterials. 86. 56–67. 17 indexed citations

12.

Mahmud, Foyez, Taslim A. Al‐Hilal, Seho Kweon, et al.. (2015). Absorption Mechanism of a Physical Complex of Monomeric Insulin and Deoxycholyl-l-lysyl-methylester in the Small Intestine. Molecular Pharmaceutics. 12(6). 1911–1920. 27 indexed citations

13.

Park, Jooho, Jiyoung Kim, Seung Rim Hwang, Foyez Mahmud, & Youngro Byun. (2015). Chemical Conjugate of Low Molecular Weight Heparin and Suramin Fragment Inhibits Tumor Growth Possibly by Blocking VEGF₁₆₅. Molecular Pharmaceutics. 12(11). 3935–3942. 19 indexed citations

14.

Alam, Farzana, Taslim A. Al‐Hilal, Seung Woo Chung, et al.. (2014). Oral delivery of a potent anti-angiogenic heparin conjugate by chemical conjugation and physical complexation using deoxycholic acid. Biomaterials. 35(24). 6543–6552. 42 indexed citations

15.

Alam, Farzana, Taslim A. Al‐Hilal, Seung Woo Chung, et al.. (2014). Functionalized heparin-protamine based self-assembled nanocomplex for efficient anti-angiogenic therapy. Journal of Controlled Release. 197. 180–189. 16 indexed citations

16.

Mahmud, Foyez, et al.. (2012). Insight of current technologies for oral delivery of proteins and peptides. Drug Discovery Today Technologies. 9(2). e105–e112. 25 indexed citations

17.

Mahmud, Foyez, et al.. (1989). Congenital central nervous system anomalies.. Radiographics. 9(5). 801–826. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact